Full Text View
Tabular View
No Study Results Posted
Related Studies
Subcutaneous Omalizumab for Treatment of Chronic Rhinosinusitis With Nasal Polyposis (Xolair CRS)
This study is currently recruiting participants.
Verified March 2013 by Massachusetts General Hospital
Study NCT01066104   Information provided by Massachusetts General Hospital

First Received on February 8, 2010.   Last Updated on March 6, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Additional conditions recognized in this trial
More general conditions related to this trial
Interventions listed in this trial
Additional drug interventions recognized in this trial
More general drug interventions related to this trial
Sponsors listed in this trial